Submitted by Anonymous (not verified) on 13 October 2023 - 10:07
Human medicines European public assessment report (EPAR): Farydak, panobinostat, Multiple Myeloma, Date of authorisation: 28/08/2015, Revision: 13, Status: Authorised
Source: